Celiprolol may help lower the risk of fatal vascular complications while also providing psychological reassurance for people with vascular Ehlers-Danlos syndrome (vEDS), according to the first study of the treatment conducted outside Europe. In the Japanese study, nearly half of the patients experienced no vascular or nonvascular complications…